` 301033 (Medprin Regenerative Medical Technologies Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

301033
vs
S
Shanghai Composite

Over the past 12 months, Medprin Regenerative Medical Technologies Co Ltd has significantly outperformed Shanghai Composite, delivering a return of +56% compared to the Shanghai Composite's +23% growth.

Stocks Performance
301033 vs Shanghai Composite

Loading
301033
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
301033 vs Shanghai Composite

Loading
301033
Shanghai Composite
Difference
www.alphaspread.com

Performance By Year
301033 vs Shanghai Composite

Loading
301033
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Medprin Regenerative Medical Technologies Co Ltd vs Peers

Shanghai Composite
301033
LEG
PMT
DFS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Medprin Regenerative Medical Technologies Co Ltd
Glance View

Market Cap
4.9B CNY
Industry
Health Care

Medprin Regenerative Medical Technologies Co. Ltd. engages in the development of implanted medical devices. The company is headquartered in Guangzhou, Guangdong and currently employs 271 full-time employees. The company went IPO on 2021-07-26. The firm's implanted medical device products include artificial dura mater (spine) patch, cranio-maxillofacial repair products and absorbable hemostatic yarns. 3D printing equipment includes biological 3D printers, resin 3D printers and other related supporting components. Technical services include general technical services and scientific research services. The firm distributes its products both in the domestic market and to overseas markets.

Intrinsic Value
65.88 CNY
Overvaluation 10%
Intrinsic Value
Price
Back to Top